Decision to list medical devices

Hospital devices

Decision

We are pleased to announce the approval of listing agreements for medical devices with 3M New Zealand Limited, Big Green Surgical Company, Mӧlnlycke Health Care Pty Ltd, New Zealand Medical & Scientific Limited and WM Bamford & Co Limited.

What we are doing

We are pleased to announce the approval of listing agreements for the following medical devices.

Supplier

Category of Medical Device

3M New Zealand Limited (“3M”)

  • Endomechanical and electrosurgical medical devices
  • Patient warming and cooling

Big Green Surgical Company (“Big Green Surgical”)

  • Endomechanical and electrosurgical medical devices

Mölnlycke Health Care Pty Ltd (“Mölnlycke”)

  • Endomechanical and electrosurgical medical devices
  • Patient warming and cooling

New Zealand Medical & Scientific Limited (“NZMS”)

  • Patient warming and cooling

W M Bamford & Co Limited (“W M Bamford”)

  • Endomechanical and electrosurgical medical devices
  • Patient warming and cooling
  • Respiratory equipment and consumables

In summary this will result in:

  • Medical devices, from the suppliers and in the categories listed above, being listed on the Pharmaceutical Schedule from 1 April 2019 under national agreements that all DHBs may purchase under (“Agreements”); and
  • DHBs continuing to be able to purchase other suppliers’ brands of medical devices in the endomechanical and electrosurgical medical devices, patient warming and cooling and respiratory care products categories. 

Any changes to the original proposal?

This decision was subject to a consultation letter dated 28 January 2019.

No changes have been made to the agreements as a result of consultation. 

Who we think will be most interested

  • Suppliers and Wholesalers
  • DHB Staff:
    • Clinical Engineers
    • Anaesthetists and Anaesthetic Technicians
    • Clinical staff involved with airway management and emergency respiratory resuscitation
    • ICU Clinicians
    • Perioperative clinicians
    • Pulmonary function specialists
    • Pulmonary rehabilitation specialists
    • Respiratory clinicians
    • Respiratory therapists
    • DHB procurement and warehousing personnel

Detail about this decision

PHARMAC issued Requests for Proposals (“RFPs”) for:

The RFP was for non-exclusive national agreements for listing in the Pharmaceutical Schedule.

After completing the RFP evaluation processes and consulting on the provisional Agreements reached with 3M, Big Green Surgical, Mӧlnlycke, NZMS and W M Bamford PHARMAC has decided to list the medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 April 2019.

The list of products will be available on PHARMAC's website from 1 April 2019, in both a PDF document and an Excel spreadsheet.

DHBs that purchase medical devices in these categories from the suppliers listed above must do so under the terms and conditions and at the prices included in the Agreements, from 1 April 2019. DHBs can continue to choose which endomechanical and electrosurgical medical devices, patient warming and cooling products and respiratory care products they purchase.

The Agreements include terms and conditions for training and education to be provided by the suppliers on the appropriate use and maintenance of their products, which is to be provided at times as agreed with individual DHBs.

Our response to what you told us

We appreciate the time people took to respond to this consultation.

A summary of the main themes raised in feedback and our responses to the feedback received are set out below:

Theme

Comment

Feedback that no technical or resource impacts are expected as a result of the proposal.

Noted.

Request for update on status of contract negotiation for other suppliers whose RFP responses were successful in being progressed to contract negotiations. 

Drafting of agreements with other successful suppliers is in progress.

Request to submit products for consideration for listing on the Pharmaceutical Schedule. 

The response periods have closed and PHARMAC is not accepting any new proposals in relation to the RFPs. 

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.